Index RUT P/E - EPS (ttm) -1.03 Insider Own 26.23% Shs Outstand 61.75M Perf Week 6.47%
Market Cap 339.02M Forward P/E - EPS next Y -0.76 Insider Trans 9.38% Shs Float 45.88M Perf Month -15.48%
Income -63.68M PEG - EPS next Q -0.27 Inst Own 63.92% Short Float 8.90% Perf Quarter -8.23%
Sales 198.53M P/S 1.71 EPS this Y -15.84% Inst Trans 10.81% Short Ratio 4.99 Perf Half Y -56.60%
Book/sh 1.80 P/B 3.02 EPS next Y 19.44% ROA -26.77% Short Interest 4.08M Perf Year -60.75%
Cash/sh 1.53 P/C 3.57 EPS next 5Y - ROE -48.60% 52W Range 3.92 - 15.98 Perf YTD -57.24%
Dividend Est. - P/FCF - EPS past 5Y -70.68% ROI -35.07% 52W High -65.89% Beta 0.21
Dividend TTM - Quick Ratio 2.93 Sales past 5Y 48.07% Gross Margin 80.67% 52W Low 39.06% ATR (14) 0.37
Dividend Ex-Date - Current Ratio 3.86 EPS Y/Y TTM -41.65% Oper. Margin -32.72% RSI (14) 43.67 Volatility 6.56% 5.74%
Employees 516 Debt/Eq 0.62 Sales Y/Y TTM 18.90% Profit Margin -32.08% Recom 3.00 Target Price 7.40
Option/Short Yes / Yes LT Debt/Eq 0.62 EPS Q/Q -70.89% Payout - Rel Volume 0.44 Prev Close 5.60
Sales Surprise 3.39% EPS Surprise -16.92% Sales Q/Q 5.96% Earnings Aug 06 AMC Avg Volume 817.41K Price 5.45
SMA20 -3.53% SMA50 -16.10% SMA200 -42.52% Trades
Volume 315,796 Change -2.66%
Date
Action
Analyst
Rating Change
Price Target Change
May-16-24 Downgrade UBS
Buy → Neutral
$16 → $6.50
May-08-24 Downgrade Truist
Buy → Hold
$17 → $7
May-08-24 Downgrade Stifel
Buy → Hold
$15 → $6
May-08-24 Downgrade Morgan Stanley
Overweight → Equal-Weight
$15 → $5.50
May-08-24 Downgrade JP Morgan
Overweight → Neutral
$15 → $8
May-08-24 Downgrade BTIG Research
Buy → Neutral
Sep-29-23 Initiated UBS
Buy
$24
May-01-23 Initiated Truist
Buy
$33
Apr-11-23 Initiated Stephens
Equal-Weight
$26
May-12-22 Initiated BTIG Research
Buy
$22
Jan-07-22 Upgrade Morgan Stanley
Equal-Weight → Overweight
$30
May-18-21 Initiated SVB Leerink
Outperform
$38
May-18-21 Initiated Stifel
Buy
$35
May-18-21 Initiated Morgan Stanley
Equal-Weight
$30
May-18-21 Initiated JP Morgan
Overweight
$37
Show Previous Ratings
Sep-18-24 10:53AM
Sep-11-24 08:00AM
Aug-22-24 04:15PM
Aug-06-24 07:00PM
05:53PM
(Associated Press Finance)
04:05PM
Loading…
04:05PM
Jul-18-24 04:30PM
May-28-24 07:00AM
May-16-24 10:05AM
May-15-24 03:11AM
May-14-24 03:09AM
03:08AM
May-13-24 09:58AM
May-08-24 03:13PM
10:28AM
08:34AM
Loading…
08:34AM
07:42AM
07:31AM
06:44AM
03:56AM
May-07-24 09:57PM
06:15PM
05:30PM
04:38PM
(Associated Press Finance)
04:05PM
Apr-24-24 07:00AM
Apr-17-24 07:00AM
Apr-16-24 07:00AM
Apr-09-24 07:00AM
Mar-25-24 07:00AM
08:43AM
Loading…
Feb-29-24 08:43AM
Feb-27-24 06:35PM
05:28PM
(Associated Press Finance)
04:40PM
04:05PM
Feb-20-24 10:00AM
Feb-07-24 04:05PM
Feb-02-24 12:00PM
Feb-01-24 07:00AM
Jan-08-24 07:00AM
Dec-19-23 07:00AM
Dec-07-23 06:27AM
Nov-12-23 12:22PM
Nov-10-23 09:13AM
(Thomson Reuters StreetEvents) -37.90%
Nov-09-23 05:28PM
(Associated Press Finance) -6.72%
04:05PM
Oct-30-23 07:00AM
Oct-16-23 07:00AM
Sep-20-23 07:00AM
Sep-14-23 04:05PM
Sep-11-23 04:05PM
Aug-22-23 04:05PM
Aug-21-23 07:00AM
Aug-08-23 06:30PM
05:27PM
(Associated Press Finance)
04:05PM
Jul-24-23 04:05PM
Jul-18-23 04:15PM
Jul-12-23 04:15PM
Jul-10-23 08:03AM
Jun-13-23 04:15PM
Jun-12-23 07:02AM
Jun-05-23 07:56AM
Jun-01-23 04:15PM
May-09-23 09:38AM
(Thomson Reuters StreetEvents)
07:10AM
May-08-23 05:55PM
04:55PM
04:05PM
Apr-26-23 04:15PM
Apr-20-23 04:15PM
Apr-19-23 04:15PM
Apr-18-23 10:14AM
Apr-10-23 07:58AM
Apr-04-23 04:15PM
Mar-14-23 02:11PM
(American City Business Journals)
Mar-08-23 03:50PM
08:12AM
(Thomson Reuters StreetEvents)
02:07AM
(American City Business Journals)
Mar-07-23 04:05PM
Mar-03-23 09:03AM
09:03AM
Feb-27-23 04:15PM
Feb-09-23 01:00PM
Feb-07-23 09:15PM
04:30PM
Jan-31-23 05:09AM
Jan-09-23 08:00AM
Dec-21-22 05:52AM
Dec-20-22 04:15PM
Dec-19-22 04:15PM
08:50AM
Dec-01-22 08:50AM
Nov-28-22 04:15PM
Nov-21-22 04:15PM
Nov-14-22 08:50AM
Nov-10-22 05:50AM
(Simply Wall St.) +10.06%
Nov-08-22 07:15PM
04:05PM
Oct-29-22 09:10AM
Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Treace John T. Chief Executive Officer Sep 16 '24 Buy 5.31 50,000 265,630 6,523,095 Sep 17 05:17 PM Scanlan Sean F. Chief Innovation Officer Sep 12 '24 Option Exercise 0.10 33,750 3,280 250,074 Sep 16 04:30 PM TREACE JAMES T Director Aug 15 '24 Buy 5.96 84,000 501,035 1,223,441 Aug 19 09:00 AM Treace John T. Chief Executive Officer Aug 14 '24 Buy 6.00 85,000 510,314 6,473,095 Aug 15 05:30 PM Treace John T. Chief Executive Officer Jun 11 '24 Buy 5.88 45,000 264,600 6,388,095 Jun 11 05:30 PM TREACE JAMES T Director May 31 '24 Buy 6.05 25,000 151,328 1,139,441 Jun 03 04:30 PM TREACE JAMES T Director May 29 '24 Buy 5.20 25,000 130,062 1,114,441 May 30 05:04 PM TREACE JAMES T Director May 28 '24 Buy 5.07 50,000 253,475 1,089,441 May 29 04:33 PM MOTT RICHARD W Director May 22 '24 Buy 4.99 12,100 60,425 1,054,944 May 23 04:30 PM Treace John T. Chief Executive Officer May 17 '24 Buy 5.56 100,000 556,170 6,343,095 May 20 04:30 PM Kiernan Jane E Director May 14 '24 Buy 5.17 19,356 100,001 24,941 May 14 06:20 PM Treace John T. Chief Executive Officer May 14 '24 Buy 5.12 150,000 767,805 6,243,095 May 14 06:19 PM Jain Deepti Director May 10 '24 Buy 4.50 25,000 112,568 31,235 May 13 07:49 PM MOTT RICHARD W Director May 10 '24 Buy 4.57 83,198 379,849 990,951 May 13 07:48 PM MOTT RICHARD W Director May 13 '24 Buy 4.38 36,802 161,090 1,027,753 May 13 07:48 PM TREACE JAMES T Director May 13 '24 Buy 4.54 145,000 657,981 1,039,441 May 13 07:47 PM TREACE JAMES T Director May 10 '24 Buy 4.53 83,000 376,023 894,441 May 13 07:47 PM BAKEWELL JOHN K Director May 10 '24 Buy 4.57 130,000 594,620 135,048 May 13 07:30 PM Treace John T. Chief Executive Officer May 10 '24 Buy 4.58 150,000 686,880 5,943,095 May 13 06:07 PM Treace John T. Chief Executive Officer May 13 '24 Buy 4.56 150,000 683,490 6,093,095 May 13 06:07 PM
Index - P/E - EPS (ttm) -1.10 Insider Own 10.07% Shs Outstand 29.09M Perf Week 25.84%
Market Cap 27.87M Forward P/E - EPS next Y -0.63 Insider Trans 11.36% Shs Float 27.25M Perf Month -7.32%
Income -32.47M PEG - EPS next Q -0.23 Inst Own 53.03% Short Float 2.04% Perf Quarter -49.73%
Sales 72.06M P/S 0.39 EPS this Y 16.36% Inst Trans -1.96% Short Ratio 1.53 Perf Half Y -78.56%
Book/sh 0.64 P/B 1.43 EPS next Y 28.70% ROA -32.93% Short Interest 0.56M Perf Year -32.36%
Cash/sh 1.43 P/C 0.64 EPS next 5Y - ROE -100.13% 52W Range 0.66 - 5.07 Perf YTD -68.28%
Dividend Est. - P/FCF - EPS past 5Y 17.12% ROI -48.08% 52W High -81.86% Beta 2.28
Dividend TTM - Quick Ratio 2.37 Sales past 5Y 7.39% Gross Margin 70.33% 52W Low 38.54% ATR (14) 0.09
Dividend Ex-Date - Current Ratio 2.58 EPS Y/Y TTM 2.56% Oper. Margin -39.78% RSI (14) 44.76 Volatility 11.77% 7.77%
Employees 203 Debt/Eq 3.23 Sales Y/Y TTM 6.22% Profit Margin -45.06% Recom 1.50 Target Price 3.33
Option/Short Yes / Yes LT Debt/Eq 2.48 EPS Q/Q -90.90% Payout - Rel Volume 1.14 Prev Close 0.95
Sales Surprise -11.78% EPS Surprise -22.59% Sales Q/Q -6.59% Earnings Aug 12 BMO Avg Volume 362.88K Price 0.92
SMA20 7.85% SMA50 -30.00% SMA200 -64.48% Trades
Volume 359,599 Change -2.90%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-13-24 Downgrade William Blair
Outperform → Mkt Perform
Oct-13-21 Downgrade William Blair
Outperform → Mkt Perform
Oct-13-21 Downgrade BTIG Research
Buy → Neutral
Jan-22-21 Upgrade William Blair
Mkt Perform → Outperform
Feb-06-20 Initiated BTIG Research
Buy
$11
Jul-24-18 Initiated Canaccord Genuity
Buy
Sep-19-24 08:31AM
Sep-16-24 08:32AM
Sep-03-24 08:29AM
Aug-20-24 08:29AM
Aug-15-24 05:42AM
12:56PM
Loading…
Aug-13-24 12:56PM
12:47PM
09:45AM
Aug-12-24 08:25AM
07:19AM
(Associated Press Finance)
07:15AM
07:10AM
Aug-05-24 04:36PM
Aug-01-24 08:29AM
Jul-31-24 08:30AM
08:30AM
Loading…
Jul-30-24 08:30AM
Jul-29-24 08:30AM
Jul-22-24 08:31AM
Jul-18-24 10:30AM
Jul-11-24 12:53PM
08:36AM
Jul-10-24 08:32AM
07:23AM
Jul-02-24 10:40AM
Jul-01-24 08:02AM
Jun-13-24 08:31AM
Jun-07-24 02:38AM
May-23-24 08:30AM
May-15-24 07:32AM
May-08-24 09:30AM
03:15AM
Loading…
03:15AM
May-07-24 11:34PM
(Thomson Reuters StreetEvents) -30.67%
08:58AM
08:40AM
07:40AM
(Associated Press Finance)
07:30AM
May-03-24 04:30PM
May-01-24 08:31AM
Apr-23-24 04:30PM
Apr-10-24 08:31AM
Apr-01-24 10:52AM
Mar-27-24 04:30PM
01:10AM
Mar-25-24 08:30AM
Mar-08-24 08:06AM
Mar-07-24 02:00PM
10:16AM
08:22AM
Mar-05-24 11:39PM
(Thomson Reuters StreetEvents) +15.41%
+24.84%
08:40AM
07:46AM
(Associated Press Finance)
07:30AM
Feb-20-24 08:30AM
Feb-12-24 08:32AM
Feb-06-24 08:28AM
Jan-08-24 08:30AM
Dec-18-23 08:49AM
Dec-04-23 08:56AM
Nov-15-23 04:15PM
Nov-13-23 08:57AM
Nov-09-23 08:32AM
Nov-08-23 01:16PM
Nov-07-23 07:57AM
07:43AM
(Associated Press Finance)
07:30AM
Nov-06-23 04:30PM
Oct-24-23 08:30AM
Oct-16-23 08:56AM
Oct-03-23 09:21AM
Sep-12-23 08:56AM
Aug-21-23 08:56AM
Aug-18-23 09:02PM
Aug-14-23 09:02AM
Aug-11-23 12:00PM
Aug-08-23 08:22AM
(Associated Press Finance)
07:30AM
Aug-04-23 04:30PM
Jul-25-23 08:30AM
Jul-19-23 08:56AM
Jul-17-23 08:46AM
Jul-11-23 08:56AM
Jun-12-23 11:25AM
11:18AM
08:59AM
Jun-09-23 09:50AM
08:53AM
Jun-08-23 12:18PM
09:31AM
Jun-06-23 11:19AM
08:04AM
Jun-02-23 10:26AM
08:33AM
Jun-01-23 08:39AM
May-31-23 09:16AM
May-30-23 01:50PM
May-29-23 02:06AM
May-26-23 08:59AM
May-25-23 12:25PM
May-24-23 04:30PM
09:34AM
Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. It operates through United States and International geographical segments. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon, and Thomas D. Weldon in 1998 and is headquartered in Malvern, PA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
CASCELLA ROBERT Director Sep 12 '24 Buy 0.75 100,000 75,000 453,098 Sep 13 05:02 PM MUIR GLENN P Director Sep 05 '24 Buy 0.80 25,000 20,000 289,818 Sep 06 05:05 PM MUIR GLENN P Director Aug 28 '24 Buy 0.85 12,776 10,860 252,594 Aug 30 05:15 PM MUIR GLENN P Director Aug 29 '24 Buy 0.85 12,224 10,390 264,818 Aug 30 05:15 PM MUIR GLENN P Director Aug 20 '24 Buy 1.00 25,000 25,000 239,818 Aug 21 05:15 PM CASCELLA ROBERT Director Aug 16 '24 Buy 1.06 35,000 37,100 349,098 Aug 19 05:13 PM CASCELLA ROBERT Director Aug 19 '24 Buy 1.14 4,000 4,560 353,098 Aug 19 05:13 PM CASCELLA ROBERT Director Aug 15 '24 Buy 0.88 35,000 30,800 314,098 Aug 16 05:15 PM CASCELLA ROBERT Director Aug 14 '24 Buy 0.79 35,000 27,650 279,098 Aug 16 05:15 PM MUIR GLENN P Director Aug 14 '24 Buy 0.75 25,171 18,878 214,818 Aug 16 05:15 PM Sullivan Keith J President and CEO Jul 18 '24 Sale 1.90 24,162 45,908 1,324,354 Jul 22 05:23 PM Sullivan Keith J President and CEO Jul 16 '24 Sale 1.91 12,075 23,063 1,360,203 Jul 18 05:21 PM Sullivan Keith J President and CEO Jul 17 '24 Sale 1.97 11,687 23,023 1,348,516 Jul 18 05:21 PM CASCELLA ROBERT Director Jun 06 '24 Buy 2.05 50,000 102,550 244,098 Jun 06 05:15 PM MACAN WILLIAM ANDREW EVP, GC, CCO and CS Feb 28 '24 Sale 3.16 22,377 70,711 395,359 Mar 01 05:02 PM MACAN WILLIAM ANDREW EVP, GC, CCO and CS Feb 29 '24 Sale 2.94 6,026 17,716 389,333 Mar 01 05:02 PM Furlong Stephen EVP, CFO and Treasurer Feb 27 '24 Sale 3.33 21,272 70,836 487,761 Feb 29 05:02 PM Furlong Stephen EVP, CFO and Treasurer Feb 28 '24 Sale 3.16 3,985 12,593 483,776 Feb 29 05:02 PM Sullivan Keith J President and CEO Feb 26 '24 Sale 3.30 20,292 66,964 1,372,278 Feb 28 05:02 PM Sullivan Keith J President and CEO Feb 22 '24 Sale 3.23 20,851 67,349 1,413,320 Feb 26 05:21 PM Sullivan Keith J President and CEO Feb 23 '24 Sale 3.23 20,750 67,022 1,392,570 Feb 26 05:21 PM Sullivan Keith J President and CEO Feb 20 '24 Sale 2.96 23,958 70,916 1,434,171 Feb 22 05:02 PM MACAN WILLIAM ANDREW EVP, GC, CCO and CS Feb 14 '24 Sale 3.38 15,621 52,799 417,736 Feb 16 05:11 PM Furlong Stephen EVP, CFO and Treasurer Feb 09 '24 Sale 3.51 14,710 51,632 509,033 Feb 13 06:00 PM MACAN WILLIAM ANDREW EVP, GC, CCO and CS Feb 06 '24 Sale 3.39 5,385 18,255 433,357 Feb 07 05:42 PM Furlong Stephen EVP, CFO and Treasurer Feb 06 '24 Sale 3.39 5,813 19,706 523,743 Feb 07 05:41 PM Sullivan Keith J President and CEO Jan 10 '24 Sale 3.01 10,013 30,139 1,167,645 Jan 12 06:00 PM Sullivan Keith J President and CEO Jan 11 '24 Sale 3.16 9,516 30,071 1,158,129 Jan 12 06:00 PM MACAN WILLIAM ANDREW EVP, GC, CCO and CS Dec 20 '23 Sale 2.70 11,664 31,493 360,405 Dec 21 07:42 PM MACAN WILLIAM ANDREW EVP, GC, CCO and CS Dec 21 '23 Sale 2.52 11,663 29,391 348,742 Dec 21 07:42 PM MACAN WILLIAM ANDREW EVP, GC, CCO and CS Dec 19 '23 Sale 2.24 11,664 26,127 372,069 Dec 21 07:42 PM MACAN WILLIAM ANDREW EVP, GC, CCO and CS Oct 06 '23 Sale 1.16 1,469 1,697 383,733 Oct 10 05:12 PM Furlong Stephen EVP, CFO and Treasurer Oct 06 '23 Sale 1.16 1,499 1,731 429,556 Oct 10 05:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
